naltrexone oral
Selected indexed studies
- Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. (JAMA, 2023) [PMID:37934220]
- Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. (JAMA Intern Med, 2025) [PMID:40257810]
- Extended-release naltrexone versus oral naltrexone for substance use disorders: A systematic review and meta-analysis. (Drug Alcohol Depend, 2025) [PMID:40660643]
_Worker-drafted node — pending editorial review._
Connections
naltrexone oral is a side effect of
Sources
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. (2014) pubmed
- Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. (2023) pubmed
- Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. (2025) pubmed
- Extended-release naltrexone versus oral naltrexone for substance use disorders: A systematic review and meta-analysis. (2025) pubmed
- Bupropion and Naltrexone in Methamphetamine Use Disorder. (2021) pubmed
- Oral naltrexone maintenance treatment for opioid dependence. (2011) pubmed
- Oral naltrexone maintenance treatment for opioid dependence. (2011) pubmed
- Oral naltrexone maintenance treatment for opioid dependence. (2006) pubmed
- Naltrexone accelerated oral traumatic ulcer healing and downregulated TLR-4/NF-kB pathway in Wistar rats. (2024) pubmed
- Oral naltrexone in the treatment of lichen planopilaris and frontal fibrosing alopecia. (2024) pubmed